comparemela.com
Home
Live Updates
Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures : comparemela.com
Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures
/PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that the U.S. Food and Drug Administration...
Related Keywords
Alexander Sah ,
Ira Duarte ,
Drug Administration ,
Exchange Commission ,
Nasdaq ,
Sah Orthopaedic Associates ,
Heron Therapeutics Inc ,
European Union ,
Heron Therapeutics ,
New Drug Application ,
Vial Access Needle ,
Craig Collard ,
Chief Executive Officer ,
Bill Forbes ,
Executive Vice President ,
Chief Development Officer ,
Sah Orthopaedic ,
Safety Information ,
Prescribing Information ,
European Commission ,
United Kingdom Regulatory Authority ,
Private Securities Litigation Reform Act ,
Boxed Warning ,
Media Contact ,
Vice President ,
Chief Financial ,
Nc ,
comparemela.com © 2020. All Rights Reserved.